Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease.

JGH Open · 2020 · PMC7273736 · PMID 32514446

Europe PMC DOI

hedged sentence

0.4400

closest p · 8.8× alpha

0.4400

boldest claim

The sentences

did not reach statistical significanceP = 0.44not close (p > 0.1)

However, the referred study only consisted of 34 patients, and the result did not reach statistical significance ( P = 0.44). 32 Serum albumin levels have not been widely used as a marker of disease activity in Crohn's disease.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.